angioClast
-
2015
Company Description
angioClast is a Cambridge biotech startup comitted to transform cancer research.
angioClast is a Cambridge biotech startup comitted to transform cancer research. Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types.
-
Manufacturer:
Science and Engineering -
Formed:
2015 -
Founders:
Minaam Abbas -
Company Website:
-
Company E-mail:
-
Company Address:
Accelerate Cambridge, Trumpington StreetUnited KingdomCambridge -
CEO:
- Minaam Abbas
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits